Home/Neuroplast/Johannes de Munter, MD, PhD
JD

Johannes de Munter, MD, PhD

Chief Executive Officer

Neuroplast

Neuroplast Pipeline

DrugIndicationPhase
Neuro-Cells®Spinal Cord Injury (SCI)Phase 1/2